Tocilizumab for refractory <scp>post‐COVID</scp>‐19 pansclerotic morphea-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tocilizumab for refractory post‐COVID‐19 pansclerotic morphea

Published:2023-12-11 Issue: Volume: Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Saraswat Neerja¹,Tripathy Durga Madhab²^ORCID,Mishra Abhishek³,Kumar Abhishek⁴,Kartik Sivasami⁴,Gopal Manoj M.⁵

Affiliation:

1. Dermatology Military Hospital Udhampur India

2. Dermatology Military Hospital Agra India

3. Radiodiagnosis Military Hospital Udhampur India

4. Medicine & Rheumatology Army Hospital (R&R) New Delhi India

5. Pathology and Histopathology Command Hospital Lucknow India

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.19692

Reference7 articles.

1. Two Years into the COVID-19 Pandemic: Lessons Learned

2. Pansclerotic Morphea Following COVID-19: A Case Report and Review of Literature on Rheumatologic and Non-rheumatologic Dermatologic Immune-Mediated Disorders Induced by SARS-CoV-2

3. Morphea Profunda Presenting As a Neuromuscular Mimic

4. Facial solitary morphea profunda presenting with painful trigeminal neuropathy: A case report

5. Tocilizumab in two children with pansclerotic morphea: a hopeful therapy for refractory cases?;Martini G;Clin Exp Rheumatol,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP